Magnani, A.
Semeraro, M.
Adam, F. https://orcid.org/0000-0001-6603-2687
Booth, C.
Dupré, L.
Morris, E. C. https://orcid.org/0000-0003-4834-1130
Gabrion, A.
Roudaut, C.
Borgel, D.
Toubert, A. https://orcid.org/0000-0002-7308-7317
Clave, E. https://orcid.org/0000-0001-8217-5039
Abdo, C.
Gorochov, G.
Petermann, R.
Guiot, M.
Miyara, M.
Moshous, D.
Magrin, E.
Denis, A.
Suarez, F.
Lagresle, C. https://orcid.org/0000-0002-2216-6453
Roche, A. M.
Everett, J.
Trinquand, A.
Guisset, M.
Bayford, J. Xu
Hacein-Bey-Abina, S.
Kauskot, A. https://orcid.org/0000-0002-4064-8114
Elfeky, R.
Rivat, C.
Abbas, S.
Gaspar, H. B.
Macintyre, E. https://orcid.org/0000-0003-0520-0493
Picard, C.
Bushman, F. D. https://orcid.org/0000-0003-4740-4056
Galy, A.
Fischer, A. https://orcid.org/0000-0003-4025-5983
Six, E. https://orcid.org/0000-0001-7806-0968
Thrasher, A. J. https://orcid.org/0000-0002-6097-6115
Cavazzana, M. https://orcid.org/0000-0002-0264-0891
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-10-IAHU-01)
Article History
Received: 29 January 2021
Accepted: 24 November 2021
First Online: 24 January 2022
Change Date: 9 August 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-022-01985-y
Competing interests
: A.J.T. holds equity in Orchard Therapeutics. A. Galy and S.A. work at Genethon (sponsor). All other authors declare no competing interests.